Department of Cardiovascular Surgery, Qingdao Municipal Hospital, Medical College of Qingdao University, Qingdao, Shandong, China.
Anatol J Cardiol. 2023 Apr;27(4):197-204. doi: 10.14744/AnatolJCardiol.2022.2644.
To explore the prognosis and risk factors of postoperative hepatic dysfunction in patients with acute type A aortic dissection.
A total of 156 patients who underwent surgery for acute type A aortic dissection in our hospital from May 2014 to May 2018 were retrospectively enrolled. The patients were divided into 2 groups based on postoperative liver function. The postop-erative model for end-stage liver disease score was used to define hepatic dysfunction. There were 35 patients with postoperative hepatic dysfunction (group hepatic dysfunction, model for end-stage liver disease score ≥ 15) and 121 patients without postoperative hepatic dysfunction (group non-hepatic dysfunction, model for end-stage liver disease score < 15). Univariate and multiple analyses (logistic regression) were used to identify the predictive risk factors.
In-hospital mortality rate was 8.3%. Multiple logistic analysis showed that preoperative alanine aminotransferase (P <.001), cardiopulmonary bypass time (P <.001), and red blood cell transfusion (P <.001) were independent determinants for postoperative hepatic dysfunction. The patients were followed up for 2 years, with an average follow-up of 22.9 ± 3.2 months, and the lost follow-up rate was 9.1%. The short- and medium-term mortality in hepatic dysfunction group was higher than that in non-hepatic dysfunction group (log-rank P =.009).
The incidence of postoperative hepatic dysfunction is high in patients with acute type A aortic dissection. Preoperative alanine aminotransferase, cardiopulmonary bypass time, and red blood cell transfusion were independent risk factors for those patients. The short- and medium-term mortality in hepatic dysfunction group was higher than that in non-hepatic dysfunction group.
探讨急性 A 型主动脉夹层术后肝功能障碍的预后及危险因素。
回顾性分析 2014 年 5 月至 2018 年 5 月我院收治的 156 例行手术治疗的急性 A 型主动脉夹层患者的临床资料,根据术后肝功能将患者分为两组,采用终末期肝病模型评分定义肝功能障碍,术后肝功能障碍 35 例(肝功能障碍组,终末期肝病模型评分≥15 分),术后无肝功能障碍 121 例(非肝功能障碍组,终末期肝病模型评分<15 分)。采用单因素及多因素分析(logistic 回归)识别预测肝功能障碍的危险因素。
住院死亡率为 8.3%。多因素 logistic 分析显示,术前丙氨酸氨基转移酶(P<0.001)、体外循环时间(P<0.001)和红细胞输注(P<0.001)是术后肝功能障碍的独立决定因素。患者平均随访 22.9±3.2 个月(失访率为 9.1%),随访期间肝功能障碍组的短期和中期死亡率高于非肝功能障碍组(log-rank P=0.009)。
急性 A 型主动脉夹层术后肝功能障碍发生率较高,术前丙氨酸氨基转移酶、体外循环时间和红细胞输注是其独立危险因素,肝功能障碍组的短期和中期死亡率高于非肝功能障碍组。